awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q27026478-E47EC8DB-B28D-4A92-B354-6C6B1C5AD8A3
Q27026478-E47EC8DB-B28D-4A92-B354-6C6B1C5AD8A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27026478-E47EC8DB-B28D-4A92-B354-6C6B1C5AD8A3
Evolving Paradigms in the Management of Multiple Myeloma: Novel Agents and Targeted Therapies
P2860
Q27026478-E47EC8DB-B28D-4A92-B354-6C6B1C5AD8A3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q27026478-E47EC8DB-B28D-4A92-B354-6C6B1C5AD8A3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fd35c28061189722c61f1331ed1e97ffc01184ed
P2860
Vorinostat or placebo in combination with bortezomib in patients with multiple myeloma (VANTAGE 088): a multicentre, randomised, double-blind study.